<bill session="115" type="h" number="3991" updated="2019-04-18T16:16:15Z">
  <state datetime="2017-10-06">REFERRED</state>
  <status>
    <introduced datetime="2017-10-06"/>
  </status>
  <introduced datetime="2017-10-06"/>
  <titles>
    <title type="official" as="introduced">To amend section 303(g)(2) of the Controlled Substances Act to allow certain pharmacists to dispense narcotic drugs for maintenance or detoxification treatment pursuant to the same waiver provisions as apply with respect to nurse practitioners and physician assistants.</title>
    <title type="short" as="introduced">Expanded Access to Opioid Abuse Treatment Act of 2017</title>
    <title type="short" as="introduced">Expanded Access to Opioid Abuse Treatment Act of 2017</title>
    <title type="display">Expanded Access to Opioid Abuse Treatment Act of 2017</title>
  </titles>
  <sponsor bioguide_id="L000580"/>
  <cosponsors>
    <cosponsor bioguide_id="C000984" joined="2017-10-27"/>
  </cosponsors>
  <actions>
    <action datetime="2017-10-06">
      <text>Introduced in House</text>
    </action>
    <action datetime="2017-10-06" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2017-10-06">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2017-10-13">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2017-10-16">
      <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSJU" name="House Judiciary" activity="Referral"/>
    <committee subcommittee="Crime, Terrorism, and Homeland Security" code="HSJU08" name="House Judiciary" activity="Referral"/>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Drug therapy"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Health personnel"/>
  </subjects>
  <amendments/>
  <summary date="2017-10-06T04:00:00Z" status="Introduced in House">Expanded Access to Opioid Abuse Treatment Act of 2017

This bill amends the Controlled Substances Act to allow a pharmacist who meets specified criteria to be a qualifying practitioner who may administer, dispense, or prescribe narcotic drugs for maintenance or detoxification treatment in an office-based opioid treatment program.</summary>
  <committee-reports/>
</bill>
